Dagajas, Ashira Adiya P.

HRN: 21-35-18  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/05/2024
CEFTRIAXONE 1G (VIAL)
07/05/2024
07/12/2024
IV
450 Mg
Q12
PCAP C
Waiting Final Action 
07/09/2024
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
07/09/2024
07/14/2024
PO
2.2ml
OD
PCAP-C
Waiting Final Action 
07/13/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/13/2024
07/19/2024
IV
450mg
Q6
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: